Table 1.
Characteristics | Total (n=96) | Disease severity | P value | |
---|---|---|---|---|
Mild (n=22) | Severe (n=74) | |||
Median (interquartile range) age (years) | 55 (44.3-64.8) | 47.5 (36.8-56.3) | 57 (47.5-66) | 0.01 |
Men | 58 (60) | 9 (41) | 49 (66) | 0.03 |
Infected in Wuhan | 28 (29) | 2 (9) | 26 (35) | 0.01 |
Underlying diseases: | ||||
Hypertension | 35 (36) | 4 (18) | 31 (42) | 0.04 |
Diabetes mellitus | 11 (11) | 1 (5) | 10 (14) | 0.44 |
Heart disease | 7 (7) | 0 (0) | 7 (9) | 0.30 |
Lung disease | 4 (4) | 0 (0) | 4 (5) | 0.57 |
Liver disease | 3 (3) | 1 (5) | 2 (3) | 0.55 |
Renal disease | 1 (1) | 0 (0) | 1 (1) | 1.00 |
Malignancy | 1 (1) | 0 (0) | 1 (1) | 1.00 |
Immune compromise | 1 (1) | 0 (0) | 1 (1) | 1.00 |
Symptoms: | ||||
Fever | 85 (89) | 17 (77) | 68 (92) | 0.13 |
Cough | 54 (56) | 12 (55) | 42 (57) | 0.85 |
Sputum | 26 (27) | 7 (32) | 19 (26) | 0.59 |
Chest distress | 12 (13) | 2 (9) | 10 (14) | 0.85 |
Dizziness | 7 (7) | 0 (0) | 7 (9) | 0.30 |
Headache | 4 (4) | 0 (0) | 4 (5) | 0.57 |
Nausea | 5 (5) | 2 (9) | 3 (4) | 0.32 |
Vomiting | 2 (2) | 0 (0) | 2 (3) | 1.00 |
Diarrhoea | 10 (10) | 0 (0) | 10 (14) | 0.15 |
Myalgia | 19 (20) | 6 (27) | 13 (18) | 0.49 |
Fatigue | 9 (9) | 1 (5) | 8 (11) | 0.64 |
Treatment: | ||||
Gammaglobulin | 53 (55) | 4 (18) | 49 (66) | <0.001 |
Glucocorticoids | 78 (81) | 9 (41) | 69 (93) | <0.001 |
Antibiotics | 33 (34) | 1 (5) | 32 (43) | 0.001 |
Antivirals | 96 (100) | 22 (100) | 74 (100) | NC |
Time from illness onset to antiviral treatment (days): | ||||
≤5 | 63 (66) | 14 (64) | 49 (66) | 0.82 |
>5 | 29 (30) | 8 (36) | 21 (28) | 0.58 |
Disease severity/support: | ||||
Bilateral pulmonary infiltrates | 80 (83) | 12 (55) | 68 (92) | <0.001 |
Invasive mechanical ventilation | 10 (10) | 0 (0) | 10 (14) | 0.15 |
ECMO | 5 (5) | 0 (0) | 5 (7) | 0.59 |
Intensive care unit admission | 30 (31) | 0 (0) | 30 (41) | <0.001 |
ECMO=extracorporeal membrane oxygenation; NC=not calculable.